Treatments for Metastatic Breast Cancer | Susan G. Komen®
Mar 23, 2026 · Susan G. Komen® Metastatic Breast Cancer (MBC) Impact Series Susan G. Komen’s MBC Impact Series provides people living with metastatic breast cancer and their loved ones a safe, …
Treatment of Stage IV (Metastatic) Breast Cancer
You can find more treatment details in Treatment for Triple-negative Breast Cancer. Local or regional treatments for stage IV breast cancer Although systemic drugs are the main treatment for stage IV …
Treatment for Metastatic Breast Cancer
Oct 1, 2025 · An interactive treatment decision-making support tool, created by the medical education organization Clinical Care Options, can also be a helpful resource for weighing your treatment …
ASCO 2025 Metastatic Breast Cancer Updates | Breast Cancer ...
Jun 19, 2025 · The takeaway These and other presentations at ASCO highlight a growing list of treatment options for MBC. More than a dozen drugs are currently in development for this form of …
What's next for metastatic breast cancer treatments? | LBBC
Dec 16, 2025 · Researchers gave insight into drugs that are being studied for use in metastatic breast cancer when the first treatment stops working.
What Are the Treatment Options for Metastatic Breast Cancer?
Mar 20, 2024 · Treatment options for metastatic breast cancer include hormone therapy, targeted therapy, chemotherapy, and immunotherapy.
Understanding Your Metastatic Breast Cancer Treatment Options
Nov 3, 2025 · Getting diagnosed with metastatic breast cancer (MBC) can be overwhelming, but it’s a diagnosis that comes with hope. Treatment today has improved significantly over the past two …
What are first-line treatments for metastatic breast cancer?
Feb 28, 2024 · In this expert interview, Dr. Michelle Azu discusses the first-line treatments for metastatic breast cancer, including recent research and the latest options.
Systemic Treatment of Patients With Metastatic Breast Cancer ...
Jan 10, 2024 · The guideline presents treatment options for patients with MBC and positive PD-L1 or BRCA1 / 2 status. For germline BRCA1 / 2 mutation–positive MBC, if poly ADP-ribose polymerase …
Plan Your HR+/HER2- MBC Treatment: Key Questions for Your Doctor
Dec 10, 2025 · Navigate HR+/HER2- metastatic breast cancer treatment by knowing which questions to ask your doctor about progression, next therapies, clinical trials, and quality of life.